Applications of nanotechnology in dermatology

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 2, 2012, Pages 964-975

  Delouise, Lisa A ^a,b  

^a University of Rochester   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NANOPARTICLE; NITRIC OXIDE; QUANTUM DOT; SILVER; VACCINE;

CELLULAR DISTRIBUTION; CYTOTOXICITY; DENDRITIC CELL; DERMATOLOGY; DRUG DELIVERY SYSTEM; HUMAN; IMMUNOMODULATION; KERATINOCYTE; LYMPH NODE; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN PENETRATION; WOUND HEALING;

EID: 84857053855     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.425     Document Type: Review

References (213)

1. Abeck M (1998) Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol 139:13-6
2. Adiseshaiah PP, Hall JB, McNeil SE (2010) Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:99-112
3. Al-Jamal WT, Al-Jamal KT, Tian B et al. (2009) Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration. Mol Pharm 6:520-30
4. Altman KW, Desai SC, Moline J et al. (2010) Odor identification ability and self-reported upper respiratory symptoms in workers at the post-9/11
5. Arts JH, Bloksma N, Leusink-Muis T et al. (2003) Respiratory allergy and pulmonary irritation to trimellitic anhydride in Brown Norway rats. Toxicol Appl Pharmacol 187:38-49 (Pubitemid 36293565)
6. AshaRani PV, Mun GLK, Hande MP et al. (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279-90
7. Baker TS, Newcomb WW, Olson NH et al. (1991) Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J 60:1445-56
8. Baroli B (2010) Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality? J Pharm Sci 99:21-50
9. Bashir SJ, Chew A-L, Anigbogu A et al. (2001) Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol 7:40-8 (Pubitemid 32060998)
10. Beck LA, Leung DY (2000) Allergen sensitization through the skin induces systemic allergic response. J Allergy Clin Immunol 106:S258-3
11. Benezra M, Penate-Medina O, Zanzonico PB et al. (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 121:2768-80
12. Benn TM, Westerhoff P (2008) Nanoparticle silver released into water from commercially available sock fabrics. Environ Sci Technol 42:4133-9 (Pubitemid 351770073)
13. Benson HA (2009) Elastic liposomes for topical and transdermal drug delivery. Curr Drug Deliv 6:217-26
14. Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759-82
15. Boles KS, Schmieder AH, Koch AW et al. (2010) MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model. FASEB J 24:4262-70
16. Bolzinger M-A, Briancom S, Chevalier Y (2011) Nanoparticles through the skin: Managing conflicting results of inorganic and organic particles in cosmetic and pharmaceutics. WIREs Nanomed Nanobiotech 3:463-78
17. Bottrill M, Green M (2011) Some aspects of quantum dot toxicity. Chem Commun 47:7039-50
18. Breuer K, Haussler S, Kapp A et al. (2002) Staphylococcus aureus: Colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 147:55-61 (Pubitemid 34779438)
19. Bronaugh RL, Stewart RF, Congdon ER (1982) Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 62:481-8 (Pubitemid 12136695)
20. Burnett ME, Wang SQ (2011) Current sunscreen controversies: A critical review. Photodermatol Photoimmunol Photomed 27:58-67
21. Buzea C, Pacheco II, Robbie K (2007) Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2:MR17
22. Camerin M, Magaraggia M, Soncin M et al. (2010) The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Eur J Cancer 46:1910-8
23. Carlson JA, Linette GP, Aplin A et al. (2007) Melanocyte receptors: Clinical implications and therapeutic relevance. Dermatol Clin 25:541-57 (Pubitemid 47454680)
24. Chaloupka K, Malam Y, Seifalian AM (2010) Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 28: 580-8
25. Chamakura K, Perez-Ballestero R, Luo Z et al. (2011) Comparison of bactericidal activities of silver nanoparticles with common chemical disinfectants. Colloids Surf B Biointerfaces 84:88-96
26. Chen XF, Prow TW, Crichton ML et al. (2009) Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release 139:212-20
27. Chen Y, Bathula SR, Yang Q et al. (2010a) Targeted nanoparticles deliver siRNA to melanoma. J Invest Dermatol 130:2790-8
28. Chen Y, Zhu X, Zhang X et al. (2010) Nanoparticles modified with tumortargeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther 18:1650-6
29. Cho K, Wang X, Nie S et al. (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310-6 (Pubitemid 351413909)
30. Choi HS, Liu W, Misra P et al. (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165-70 (Pubitemid 47538116)
31. Choi MJ, Maibach HI (2005) Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci 27:211-21 (Pubitemid 41039710)
32. Choi HS, Liu W, Liu F et al. (2010) Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 5:42-7
33. Chourasia R, Jain SK (2009) Drug targeting through pilosebaceous route. Curr Drug Targets 10:950-67
34. Christensen FM, Johnston HJ, Stone V et al. (2010) Nano-silver - feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 4:284-95
35. Clark RA, Chong B, Mirchandani N et al. (2006) The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176:4431-9 (Pubitemid 44264423)
36. Colvin V (2003) The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21:1166-70 (Pubitemid 37203347)
37. Cone JE, Farfel M (2011) World trade center health registry-a model for a nanomaterials exposure registry. J Occup Environ Med 53(6 Suppl): S48-51
38. Costa C, Conte A, Buonocore GG et al. (2011) Antimicrobial silvermontmorillonite nanoparticles to prolong the shelf life of fresh fruit salad. Int J Food Microbiol 148:164-7
39. Cui HF, Vashist SK, Al-Rubeaan K et al. (2010) Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues. Chem Res Toxicol 23:1131-47
40. Cukierman E, Pankov R, Yamada KM (2002) Cell interactions with threedimensional matrices. Curr Opin Cell Biol 14:633-9
41. Dastjerdi R, Montazer M (2010) A review on the application of inorganic nano-structured materials in the modification of textiles: Focus on antimicrobial properties. Colloids Surf B Biointerfaces 79:5-18
42. Davis ME, Zuckerman JE, Choi CHJ et al. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067-70
43. Debbage P (2009) Targeted drugs and nanomedicine: Present and future. Curr Pharm Des 15:153-72
44. De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: Applications and hazards. Int J Nanomed 3:133-49 (Pubitemid 352042401)
45. Dhar S, Kolishetti N, Lippard SJ et al. (2011) Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci USA 108:1850-5
46. Diepgen TL, Coenraads PJ (1999) The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health 72:496-506 (Pubitemid 29535197)
47. Dowling A, Cliff R, Grobert N et al. (2004) Nanoscience and Nanotechnologies: Opportunities and Uncertainties. London: The Royal Society & The Royal Academy of Engineering. Report 44, 7-10
48. Dubina M, Goldenberg G (2009) Viral-associated nonmelanoma skin cancers: A review. Am J Dermatopathol 31:561-73
49. Elder A, Vidyasagar S, DeLouise L (2009) Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:434-50
50. Elliott C (2010) The effects of silver dressings on chronic and burns wound healing. Br J Nurs 19:S32-6
51. Endo M, Hayashi T, Kim YA et al. (2004) Applications of carbon nanotubes in the twenty-first century. Phil Trans R Soc Lond A 362:2223-38 (Pubitemid 39436510)
52. Fang FC (2004) Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies. Nat Rev Micro 2:820-32 (Pubitemid 39317463)
53. Farkas J, Peter H, Christian P et al. (2011) Characterization of the effluent from a nanosilver producing washing machine. Environ Int 37: 1057-62
54. Fernando GJP, Chen XF, Prow TW et al. (2010) Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS ONE 5:e10266
55. Filipe P, Silva JN, Silva R et al. (2009) Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 22:266-75
56. Fioretti F, Mendoza-Palomares C, Helms M et al. (2010) Nanostructured assemblies for dental application. ACS Nano 4:3277-87
57. Frangioni JV (2008) New technologies for human cancer imaging. J Clin Oncol 26:4012-21
58. Friedman AJ, Han G, Navati MS et al. (2008) Sustained release nitric oxide releasing nanoparticles: Characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 19:12-20
59. Fung MC, Bowen DL (1996) Silver products for medical indications: Riskbenefit assessment. Clin Toxicol 34:119-26 (Pubitemid 26060866)
60. Gallo RL, Nakatsuji T (2011) Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 131:1974-80
61. Gao X, Cui Y, Levenson RM et al. (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969-76 (Pubitemid 39014473)
62. Geetha M, Singh AK, Asokamani R et al. (2009) Ti based biomaterials, the ultimate choice for orthopaedic implants - A review. Prog Mater Sci 54:397-425
63. Geusens B, Sanders N, Prow T et al. (2009) Cutaneous short interfering RNA therapy. Expert Opin Drug Deliv 6:1333-49
64. Geusens B, Van Gele M, Braat S et al. (2010) Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in viable epidermis of ex vivo human skin. Adv Func Mater 20:4077-90
65. Ghosh S, Spagnoli GC, Martin I et al. (2005) Three-dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study. J Cell Physiol 204:522-31 (Pubitemid 40934647)
66. Gopee NV, Roberts DW, Webb P et al. (2009) Quantitative determination of skin penetration of peg-coated cdse quantum dots in dermabraded but not intact skh-1 hairless mouse skin. Toxicol Sci 111:37-48
67. Graf C, Meinke M, Gao Q et al. (2009) Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission x-ray microscopy. J Biomed Opt 14:021015
68. Grecco ACP, Paula RFO, Mizutani E et al. (2011) Up-regulation of T lymphocyte and antibody production by inflammatory cytokines released by macrophage exposure to multi-walled carbon nanotubes. Nanotechnology 22:265103
69. Gulson B, McCall M, Korsch M et al. (2010) Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 118:140-9
70. Gwinn MR, Vallyathan V (2006) Nanoparticles: Health effects-pros and cons. Environ Health Perspect 114:1818-25
71. Hama Y, Koyama Y, Urano Y et al. (2007) Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. J Invest Dermatol 127: 2351-6 (Pubitemid 47619761)
72. Hild WA, Breunig M, Goepferich A (2008) Quantum dots-nano-sized probes for the exploration of cellular and intracellular targeting. Eur J Pharm Biopharm 68:153-68
73. Hild W, Pollinger K, Caporale A et al. (2010) G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake. Proc Natl Acad Sci USA 107:10667-72
74. Hoch M, Eberle AN, Wagner U et al. (2007) Expression and localization of melanocortin-1 receptor in human adipose tissues of severely obese patients. Obesity (Silver Spring) 15:40-9 (Pubitemid 46219782)
75. Holleran WM, Uchida Y, Halkier-Sorensen L et al. (1997) Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function. Photodermatol Photoimmunol Photomed 13:117-28 (Pubitemid 28023149)
76. Holzmann S, Tripp CH, Schmuth M et al. (2004) A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol 122:1165-74 (Pubitemid 38651091)
77. Huang HC, Barua S, Sharma G et al. (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155:344-57
78. Huang X, Peng X, Wang Y et al. (2010a) A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4:5887-96
79. Huang Y, Yu F, Park YS et al. (2010b) Coadministration of protein drugs with gold nanoparticles to enable percutaneous delivery. Biomaterials 31:9086-91
80. Ilbasmiş-Tamer S, Yilmaz S, Banoǧlu E et al. (2010) Carbon nanotubes to deliver drug molecules. J Biomed Nanotechnol 6:20-7
81. Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1:297-315
82. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-95 (Pubitemid 41057715)
83. Iyer AK, Khaled G, Fang J et al. (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discovery Today 11: 812-8 (Pubitemid 44280021)
84. Jang B, McCall M, Korsch M et al. (2010b) Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 118:140-9
85. Jang J, Lim D-H, Choi I-H (2010a) The impact of nanomaterials in immune system. Immune Netw 10:85-91
86. Jeong SH, Kim JH, Yi SM et al. (2010) Assessment of penetration of quantum dots through in vitro and in vivo human skin using the human skin equivalent model and the tape stripping method. Biochem Biophys Res Commun 394:612-5
87. Jin CY, Zhu BS, Wang XF et al. (2008) Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 21:1871-7
88. Jones ML, Ganopolsky JG, Labbé A et al. (2010) Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Appl Microbiol Biotechnol 88:401-7
89. Jun EA, Lim KM, Kim KY et al. (2011) Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 5:157-67
90. Jung WK, Koo HC, Kim KW et al. (2008) Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74:2171-8
91. Kambara T, Aihara M, Matsukura S et al. (2006) Effects of photocatalytic agent on DS-Nh mice, developing atopic dermatitis-like eruption with an increase of Staphylococcus aureus. Int Arch Allergy Immunol 141:151-7 (Pubitemid 44413290)
92. Karimipour DJ, Karimipour G, Orringer JS (2010) Microdermabrasion: An evidence-based review. Plast Reconstr Surg 25:372-7
93. Kaul G, Amiji M (2002) Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res 19:1061-7 (Pubitemid 34804251)
94. Kim C, Cho EC, Chen J et al. (2010) In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano 4:4559-64
95. Kim YC, Jarrahian C, Zehrung D et al. (2012) Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 351:77-112
96. Kirjavainen M, Urtti A, Valjakka-Koskela R et al. (1999) Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 7:279-86 (Pubitemid 29080739)
97. Koebnick C, Black MH, Smith N et al. (2011) The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatrics 159:577-83
98. Kosaka N, Ogawa M, Sato N et al. (2009) In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol 129:2818-22
99. Lademann J, Otberg N, Richter H et al. (2001) Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):17-22 (Pubitemid 34299159)
100. Lademann J, Richter H, Teichmann A et al. (2007) Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 66:159-64 (Pubitemid 46654773)
101. Lademann J, Richter H, Schanzer S et al. (2011) Penetration and storage of particles in human skin: Perspectives and safety aspects. Eur J Pharm Biopharm 77:465-8
102. Laroui H, Dalmasso G, Nguyen HT et al. (2009) Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology 138:843-53
103. Lev DC, Onn A, Melinkova VO et al. (2004) Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J Clin Oncol 22:2092-100 (Pubitemid 41095142)
104. Li D, Taylor AW (2008) Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages. J Leukoc Biol 84:191-8 (Pubitemid 351960294)
105. Li Y, Leung P, Yao L et al. (2006) Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect 62:58-63 (Pubitemid 43103011)
106. Li Z, Huang P, Lin J et al. (2010) Arginine-glycine-aspartic acid-conjugated dendrimer-modified quantum dots for targeting and imaging melanoma. J Nanosci Nanotechnol 10:4859-67
107. Lim SW, Kim HW, Jun HY et al. (2011) TCL-SPION-enhanced MRI for the detection of lymph node metastasis in murine experimental model. Acad Radiol 18:504-11
108. Lin LL, Grice JE, Butler MK et al. (2011) Time-correlated single photon counting for simultaneous monitoring of Zinc oxide nanoparticles and NAD(P)H in intact and barrier-disrupted volunteer skin. Pharm Res 28:2920-30
109. Lindemann U, Wilken K, Weigmann HJ et al. (2003) Quantification of the horny layer using tape stripping and microscopic techniques. J Biomed Opt 8:601-7
110. Loir B, Perez Sanchez C, Ghanem G et al. (1999) Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cell Mol Biol 445:1083-92
111. Long TC, Saleh N, Tilton RD et al. (2006) Titanium Dioxide (P25) produces reactive oxygen species in Immortalized brain microglia (BV2): Implications for nanoparticle neurotoxicity. Environ Sci Technol 40:4346-52 (Pubitemid 44092366)
112. Lopez RF, Seto JE, Blankschtein D et al. (2011) Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials 32:933-41
113. Low SP, Voelcker NH, Canham LT et al. (2009) The biocompatibility of porous silicon in tissues of the eye. Biomaterials 30:2873-80
114. Lu W, Xiong C, Zhang G et al. (2009) Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res 15:876-86
115. Lubick N (2008) Silver socks have cloudy lining. Environ Sci Technol 42:3910
116. Lubick N (2008a) Nanosilver toxicity: Ions, nanoparticles or both? Environ Sci Technol 42:8617
117. Luo JD, Chen AF (2005) Nitric oxide: A newly discovered function on wound healing. Acta Pharmacol Sin 26:259-64 (Pubitemid 40388060)
118. Lynch I, Cedervall T, Lundqvist M et al. (2007) The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 134-135: 167-74 (Pubitemid 47614904)
119. Lynch I, Dawson KA, Linse S (2006) Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006:pe14
120. Ma Q, Su X (2010) Near-infrared quantum dots: Synthesis, functionalization and analytical applications. Analyst 135:1867-77
121. Mahe B, Vogt A, Liard C et al. (2009) Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 129:1156-64
122. Martinez LR, Han G, Chacko M et al. (2009) Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol 129:2463-9
123. Maurer D, Stingl G (2001) Langerhans cells. In: Dendritic Cells: Biology and Clinical Applications. (Lotze MT, Thomas AW (eds), Academic Press, NY, 35-50
124. McNeela EA, Lavelle EC (2011) Recent advances in microparticle and nanoparticle delivery vehicles for mucosal vaccination. Curr Top Microbiol Immunol; e-pub ahead of print 9 September 2011
125. Menetrez MY, Foarde KK, Ensor DS (2001) An analytical method for the measurement of nonviable bioaerosols. J Air Waste Manag Assoc 51:1436-42 (Pubitemid 32976722)
126. Misra SK, Mohn D, Brunner TJ et al. (2008) Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials 29:1750-61
127. Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: Current status and future prospects. FASEB J 19:311-30 (Pubitemid 40316520)
128. Monteiro-Riviere NA, Zhang LW (2009) Assessment of Quantum Dot Penetration into Skin in Different Species Under Different Mechanical Actions. Nanomaterials: Risks and Benefits, NATO Science for Peace and Security Series C: Environmental Security. Springer Netherlands, p. 43
129. Monteiro-Riviere NA, Wiench K, Landsiedel R et al. (2011) Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: An in vitro and in vivo study. Toxicol Sci 123:264-80
130. Mortensen LJ, Glazowski CE, Zavislan JM et al. (2011) Near-IR fluorescence and reflectance confocal microscopy for imaging of quantum dots in mammalian skin. Biomed Opt Express 2:1610-25
131. Mortensen LJ, Oberdorster G, Pentland AP et al. (2008) In vivo skin penetration of quantum dot nanoparticles in the murine model: The effect of UVR. Nano Lett 8:2779-87
132. Mortensen LJ, Ravichandran S, Zheng H et al. (2010) Progress and challenges in quantifying skin permeability to nanoparticles using a quantum dot model. J Biomed Nanotechnol 6:596-604
133. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50:161-77 (Pubitemid 30326695)
134. Nakagawa Y, Wakuri S, Sakamoto K et al. (1997) The photogenotoxicity of titanium dioxide particles. Mutat Res 394:125-32
135. Nanocyclic (2008) http://nanocyclic.com/ Nanowerk (2010) Nanowerk, Nanotechnology Commercial Organizations 2010. http://www.nanowerk.com/ nanotechnology/nanomaterial/commercial-all.php
136. Nasir A (2008) Dermatologic toxicity of nanoengineered materials. Arch Dermatol 144:253-4 (Pubitemid 351287012)
137. Nasir A (2009) Nanotechnology in vaccine development: A step forward. J Invest Dermatol 129:1055-9
138. Nel A, Xia T, Mädler L et al. (2006) Toxic potential of materials at the nanolevel. Science 311:622-7 (Pubitemid 43191298)
139. Neumann AG, Nagaeva O, Mandrika I et al. (2001) MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126:441-6 (Pubitemid 34008716)
140. Nohynek GJ, Lademann J, Ribaud C et al. (2007) Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37:251-77 (Pubitemid 46440572)
141. Nohynek GJ, Dufour EK, Roberts MS (2008) Nanotechnology, cosmetics and the skin: Is there a health risk? Skin Pharmacol Physiol 21:136-49 (Pubitemid 351793742)
142. Nowack B, Krug HF, Height M (2011) 120 Years of nanosilver history: Implications for policy makers. Environ Sci Technol; e-pub ahead of print 10 January 2011
143. Nygaard UC, Hansen JS, Samuelsen M et al. (2009) Single-walled and multiwalled carbon nanotubes promote allergic immune responses in mice. Toxicol Sci 109:113-23
144. O'Meara S, Cullum N, Majid M et al. (2000) Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess 4:1-237
145. Otberg N, Richter H, Schaefer H et al. (2004) Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 122:14-9 (Pubitemid 38114633)
146. Özbaş - Turan S, Akbuǧ a J ( 2011) Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery. Drug Deliv 18:215-22
147. Pan Y, Neuss S, Leifert A et al. (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941-9 (Pubitemid 350099867)
148. Parveen S, Misra R, Sahoo SK (2011) Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine; e-pub ahead of print 7 June 2011
149. Patzelt A, Richter H, Knorr F et al. (2011) Selective follicular targeting by modification of the particle sizes. J Control Release 150:45-8
150. Paus R, Schröder JM, Reich K et al. (2006) Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes? Exp Dermatol 15:913-6 (Pubitemid 44473331)
151. Pedata P, Boccellino M, La Porta R et al. (2011) Interaction between combustion-generated organic nanoparticles and biological systems: In vitro study of cell toxicity and apoptosis in human keratinocytes. Nanotoxicology; e-pub ahead of print 16 May 2011
152. Polat BE, Hart D, Langer R et al. (2011) Ultrasound-mediated transdermal drug delivery: Mechanisms, scope, and emerging trends. J Control Release 152:330-48
153. Prow TW, Grice JE, Lin LL et al. (2011a) Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470-91
154. Prow TW, Monteiro-Riviere NA, Inman AO et al. (2011b) Quantum dot penetration into viable human skin. Nanotoxicology; e-pub ahead of print 1 April 2011
155. Rancan F, Papakostas D, Hadam S et al. (2009) Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res 26:2027-36
156. Ravichandran S, Mortensen LJ, DeLouise LA (2010) Quantification of human skin barrier function and susceptibility to quantum dot skin penetration. Nanotoxicology 5:675-86
157. Reilly DM, Green MR (1999) Eicosanoid and cytokine levels in acute skin irritation in response to tape stripping and capsaicin. Acta Derm Venereol 79:187-90 (Pubitemid 29251502)
158. Reubi JC (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Rev 24:389-427 (Pubitemid 37056239)
159. Riehemann K, Schneider SW, Luger TA et al. (2009) Nanomedicine- challenge and perspectives. Angew Chem Int Ed Engl 48:872-97
160. Rittner MN, Abraham T (1998) Nanostructured materials: An overview and commercial analysis. J Miner Met Mater Soc 50:37-8
161. Robichaud CO, Uyar AE, Darby MR et al. (2009) Estimates of upper bounds and trends in nano-TiO2 production as a basis for exposure assessment. Environ Sci Technol 43:4227-33
162. Rosenholm JM, Sahlgren C, Linden M (2011) Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr Drug Targets 12:1166-86
163. Rouse JG, Yang J, Ryman-Rasmussen JP et al. (2007) Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 7:155-60 (Pubitemid 46225845)
164. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2006) Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 127: 143-53 (Pubitemid 46005672)
165. Sadrieh N, Wokovich AM, Gopee NV et al. (2010) Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles. Toxicol Sci 115:156-66
166. Salazar-Onfray F, López M, Lundqvist MA et al. (2002) Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer 87:414-22 (Pubitemid 34983565)
167. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA (2010) Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspec 118:407-13
168. Sarfati G, Dvir T, Elkabets M et al. (2011) Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. Biomaterials 32:152-61
169. Schäfer-Korting M, Korting HC, Braun-Falco O (1989) Liposome preparations: A step forward in topical drug therapy for skin disease? A review. J Am Acad Dermatol 21:1271-5 (Pubitemid 20217001)
170. Schmieder AH, Winter PM, Caruthers SD et al. (2005) Molecular MR imaging of melanoma angiogenesis with anb3-targeted paramagnetic nanoparticles. Magn Reson Med 53:621-7 (Pubitemid 40332283)
171. Schneider M, Stracke F, Hansen S et al. (2009) Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 1:197-206
172. Schottelius M, Wester H-J (2009) Molecular imaging targeting peptide receptors. Methods 48:161-77
173. Schulz J, Hohenberg H, Pflücker F et al. (2002) Distribution of sunscreens on skin. Adv Drug Deliv Rev 54:S157-63 (Pubitemid 35379960)
174. Schwarz T (2008) 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol 84:10-8 (Pubitemid 350265098)
175. Schwarz T, Schwarz A (2011) Molecular mechanisms of ultraviolet radiationinduced immunosuppression. Eur J Cell Biol 90:560-4
176. Siegrist W, Stutz S, Eberle AN (1994) Homologous and heterologous regulation of a-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res 54:2604-10 (Pubitemid 24173745)
177. Silver S, Phung LT (1996) Bacterial heavy metal resistance: New surprises. Annu Rev Microbiol 50:753-89 (Pubitemid 26337481)
178. Simonsson C, Andersson SI, Stenfeldt AL et al. (2011) Caged fluorescent haptens reveal the generation of cryptic epitopes in allergic contact dermatitis. J Invest Dermatol 131:1486-93
179. Smijs TG, Bouwstra JA (2010) Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J Biomed Nanotechnol 6:469-84
180. Sonavane G, Tomoda K, Sano A et al. (2008) In vitro permeation of gold nanoparticles through rat skin and rat intestine: Effect of particle size. Colloids Surf B Biointerfaces 65:1-10
181. Sortino S (2010) Light-controlled nitric oxide delivering molecular assemblies. Chem Soc Rev 39:2903-13
182. Srinivasan S, Lubrano-Berthelier C, Govaerts C et al. (2004) Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114:1158-64 (Pubitemid 39578705)
183. Stensen L, Thomsen SF, Backer V (2008) Change in prevalence of atopic dermatitis between 1986 and 2001 among children. Allergy Asthma Proc 29:392-6
184. Stern ST, McNeil SE. (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4-21 (Pubitemid 350239008)
185. Stracke F, Weiss B, Lehr CM et al. (2006) Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs. J Invest Dermatol 126:2224-33 (Pubitemid 44413169)
186. Streilein JW, Lonsberry LW, Bergstresser PR (1982) Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med 155:863-71 (Pubitemid 12187859)
187. Teow Y, Asharani PV, Hande MP et al. (2011) Health impact and safety of engineered nanomaterials. Chem Commun (Camb) 47:7025-38
188. Tinkle SS, Antonini JM, Rich BA et al. (2003) Skin as a route of exposure and sensitisation in chronic beryllium disease. Environ Health Perspect 111:1202-8 (Pubitemid 36939402)
189. Todo H, Kimura E, Yasuno H et al. (2010) Permeation pathway of macromolecules and nanospheres through skin. Biol Pharm Bull 33: 1394-9
190. Tsai JC, Shen LC, Sheu HM et al. (2003) Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin. Arch Dermatol Res 295:169-74
191. Tsuji JS, Maynard AD, Howard PC et al. (2006) Research strategies for safety evaluation of nanomaterials, part iv: Risk assessment of nanoparticles. Toxicol Sci 89:42-50 (Pubitemid 43013753)
192. Vamanu CI, Hol PJ, Allouni ZE et al. (2008) Formation of potential titanium antigens based on protein binding to titanium dioxide nanoparticles. Int J Nanomed 3:69-74 (Pubitemid 351517077)
193. Vierkötter A, Schikowski T, Ranft U et al. (2010) Airborne particle exposure and extrinsic skin aging. J Invest Dermatol 130: 2719-26
194. Vogt A, Combadiere B, Hadam S et al. (2006) 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal cd1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316-22 (Pubitemid 43997914)
195. Walve JR, Bakliwal SR, Rane BR et al. (2011) Transfersomes: A surrogated carrier for transdermal drug delivery system. Int J Appl Biol Pharma Technol 2:204-13
196. Wamer WG, Yin JJ, Wei RR (1997) Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med 23:851-8 (Pubitemid 27402610)
197. Wang XW, Wang NZ, Zhang OZ et al. (1985) Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. Burns Incl Therm Inj 11:197-201 (Pubitemid 15142468)
198. Warbrick EV, Dearman RJ, Kimber I (2002) Induced changes in total serum IgE concentration in the Brown Norway rat: Potential for identification of chemical respiratory allergens. J Appl Toxicol 22:1-11 (Pubitemid 34126615)
199. Weiss MB, Andrew E, Aplin AE (2010) Paying "particle" attention to novel melanoma treatment strategies. J Invest Dermatol 130:2699-701
200. Weller R, Finnen MJ (2006) The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice. Nitric Oxide 15:395-9 (Pubitemid 44754941)
201. Wen A, Tao X, Lakkis F et al. (1999) Toxin-related a-melanocyte- stimulating hormone fusion toxin. J Biol Chem 266:12289-93
202. Wong W, Minchin RF (1996) Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] a-MSH in B16 melanoma cells. Int J Biochem Cell Biol 28:1223-32 (Pubitemid 27033138)
203. Xu A, Chai Y, Nohmi T et al. (2009) Genotoxic responses to titanium dioxide nanoparticles and fullerene in gpt delta transgenic MEF cells. Part Fibre Toxicol 6:3
204. Yanagisawa R, Takano H, Inoue K et al. (2009) Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med 234:314-22
205. Yao H, Ng SS, Huo LF et al. (2011) Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle. Mol Cancer Ther 10:1082-92
206. Zhang L, Gu FX, Chan JM et al. (2008) Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther 83:761-9 (Pubitemid 351556021)
207. Zhang LW, Monteiro-Riviere NA (2009) Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 110:138-55
208. Zhang LW, Monteiro-Riviere NA (2008a) Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacol Appl 21:166-80 (Pubitemid 351793745)
209. Zhang LW, Yu W W, Colvin VL et al. (2008b) Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharm 228:200-11
210. Zheng H, Chen G, DeLouise LA et al. (2010) Detection of the cancer marker CD146 expression in melanoma cells with semiconductor quantum dot label. J Biomed Nanotechnol 6:303-11
211. Zhou M, Nakatani E, Gronenberg LS et al. (2007) Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules. Bioconjug Chem 18:323-32 (Pubitemid 46493502)
212. Zhu X, Bidlingmair S, Hashizume R et al. (2010) Identification of internalizing human single chain antibodies targeting brain tumor sphere cells. Mol Cancer Ther 9:2131-41
213. Zolnik BS, González-Fernández A, Sadrieh N et al. (2010) Minireview: Nanoparticles and the immune system. Endocrinology 151:458-65